Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia - Top-Institutions - MDSpire

Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia

  • By

  • Shota Kato

  • Aiko Sato-Otsubo

  • Wataru Nakamura

  • Masahiro Sugawa

  • Ai Okada

  • Kenichi Chiba

  • Nao Takasugi

  • Tomoya Irikura

  • Moe Hidaka

  • Masahiro Sekiguchi

  • Kentaro Watanabe

  • Yuichi Shiraishi

  • Motohiro Kato

  • August 28, 2024

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Genomic Medicine
    • Cancer Genomics

  • #2

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Genomic Medicine
    • Translational Cancer Research

  • #3

    The University of Tokyo Hospital
    The University of Tokyo Hospital

    Tokyo, Tokyo Prefecture

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Genomic Medicine
    • Next-Generation Sequencing

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Cancer Genomics
    • Bioinformatics

  • #5

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Genomic Medicine
    • Translational Research

Original Source(s)

Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia

  • by Shota Kato, Aiko Sato-Otsubo, Wataru Nakamura, Masahiro Sugawa, Ai Okada, Kenichi Chiba, Nao Takasugi, Tomoya Irikura, Moe Hidaka, Masahiro Sekiguchi, Kentaro Watanabe, Yuichi Shiraishi, Motohiro Kato

  • August 28, 2024

Related Content

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

  • by

  • December 17, 2025

  • 4 min
Which Patients Seek Second Opinions?

A Keck Medicine of USC hematologist-oncologist shares his insights on second opinions.

  • by

  • February 26, 2025

  • 6 min
James Crawford Biggs 1931–2023